IPOS2026 Presentations Sponsors Ruemu Ejedafeta Birhiray – Introduction and Welcome: Precision Oncologics in Hematologic Malignancies Anil Sood – Precision Oncology Diagnostics: From Biomarker Identification To Clinical Application Patrick Wen – Advances in Molecularly Targeted Treatment for CNS Malignancies Justin Gainor – Targeting Oncogenic Drivers in Lung Cancer: The Role of TK Inhibitors Alex Adjei – Immunologic Strategies for Management of Lung Cancer Christine Hann – Advancing Therapeutic Targets in Small Cell Lung Cancer Heinz-Josef Lenz – Molecularly Driven Treatment Strategies in Gastrointestinal Oncology Aiwu (Ruth) He – Precision Oncology in Pancreato-Biliary Malignancies: Translating Molecular Insights into Therapy Scott Tagawa – Targeted Treatment Strategies in GU Cancers: Current Advances and Emerging Approaches Michael Davies – Evolving Treatment Paradigms in Melanoma: Targeted and Immune-Based Approaches Ruth O’Regan – Overcoming Endocrine Resistance: Emerging Targets in HR+ Breast Cancer; Advancements in Precision Oncology of Metastatic Triple-Negative Breast Cancer Heather McArthur – Advancing HER2-Positive Targeted Therapy: Translating Innovation into Practice Heather McArthur – Advancements in Precision Oncology for the Treatment for Adjuvant Therapies in Triple-Negative Breast Cancer Senthil Damodaran – Precision in Practice: When Molecular Testing in Breast Cancer Changes What You Do Senthil Damodaran – Advancements in Molecular Testing in Precision Oncology for Triple-Negative Breast Cancer Kathleen Moore – Gynecologic Cancers in the Precision Era: New Strategies, Real Impact
